Key terms
About BDTX
Black Diamond Therapeutics, Inc. is a precision oncology medicine company, which engages in discovery and development of small molecule, masterkey therapies. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest BDTX news
Apr 11
8:15am ET
Black Diamond Therapeutics announces changes to board of directors
Apr 09
7:07am ET
Black Diamond Therapeutics (BDTX) Gets a Buy from Piper Sandler
Apr 08
5:53am ET
Black Diamond Therapeutics presents preclinical data on BDTX-1535 at AACR
Apr 03
10:05pm ET
Stifel Nicolaus Remains a Buy on Black Diamond Therapeutics (BDTX)
Mar 18
6:20am ET
Analysts Offer Insights on Healthcare Companies: Black Diamond Therapeutics (BDTX) and I-MAB (IMAB)
Mar 18
6:12am ET
Black Diamond Therapeutics price target raised to $12 from $11 at H.C. Wainwright
Mar 12
1:55pm ET
Black Diamond Therapeutics (BDTX) Receives a Buy from TD Cowen
Mar 12
8:02am ET
Black Diamond Therapeutics expects cash to fund requirements into 2Q25
Mar 12
8:02am ET
Black Diamond Therapeutics reports Q4 EPS (34c), consensus (47c)
No recent press releases are available for BDTX
BDTX Financials
Key terms
Ad Feedback
BDTX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
BDTX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
